NORGALAX

This brand name is authorized in France, Netherlands, Tunisia, United Kingdom

Active ingredients

The drug NORGALAX contains one active pharmaceutical ingredient (API):

1 Docusate UNII F05Q2T2JA0 - DOCUSATE SODIUM

Docusate is an anionic wetting agent, which acts as a faecal softener by lowering the surface tension and allowing penetration of accumulated hard dry faeces by water and salts. Docusate sodium also possesses stimulant activity. Read about Docusate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NORGALAX Rectal gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A06AG10	Docusate sodium, incl. combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AG Enemas
Discover more medicines within A06AG10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 69281980
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 36093
Country: NL	Z-Index G-Standaard	Identifier(s): 13768670
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 31755
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5983011